Kiril Bidzhekov

Author PubWeight™ 27.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009 4.73
2 Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010 4.32
3 Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2007 2.85
4 Neutrophil secretion products pave the way for inflammatory monocytes. Blood 2008 2.12
5 Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2006 1.99
6 Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res 2007 1.49
7 Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 2006 1.45
8 CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J Clin Invest 2011 1.39
9 CD73/ecto-5'-nucleotidase protects against vascular inflammation and neointima formation. Circulation 2006 1.27
10 Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation 2010 1.21
11 Endothelial junctional adhesion molecule-a guides monocytes into flow-dependent predilection sites of atherosclerosis. Circulation 2013 1.18
12 C1-esterase inhibitor protects against neointima formation after arterial injury in atherosclerosis-prone mice. Circulation 2007 1.04
13 Importance of junctional adhesion molecule-C for neointimal hyperplasia and monocyte recruitment in atherosclerosis-prone mice-brief report. Arterioscler Thromb Vasc Biol 2009 0.97
14 MCP-1 induces a novel transcription factor with proapoptotic activity. Circ Res 2006 0.89
15 C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice. Circulation 2010 0.88
16 Recurrent spontaneous coronary dissections in a patient with a de novo fibrillin-1 mutation without Marfan syndrome. Thromb Haemost 2014 0.75